Literature DB >> 2957786

Activation of resting, pure CD4+, and CD8+ cells via CD3. Requirements for second signals.

R Halvorsen, G Gaudernack, T Leivestad, F Vartdal, E Thorsby.   

Abstract

We studied the requirements for secondary activation signals in pure CD4+ and CD8+ T cells after stimulation with anti-CD3 antibodies. Stimulation of CD4+ or CD8+ cells with anti-CD3 monoclonal antibodies (MoAb) bound to polystyrene monosized particles never resulted in a proliferative response. However, DNA synthesis was observed when recombinant interleukin 2 (IL-2) or other secondary signals, such as those provided by phorbol myristate acetate (PMA) or autologous accessory cells (AC), were also added. These secondary signals were not in themselves capable of inducing DNA synthesis in the absence of particle-bound anti-CD3. We also found that the signals provided by AC may be dependent on the activation state of these cells. Thus, the effects of accessory cells were enhanced by a factor present in fetal calf serum (FCS), most likely endotoxin or lipopolysaccharide (LPS), which alone, however, were not able to activate T cells, even in the presence of particle-bound anti-CD3. Recombinant IL-1 over a broad dose range was unable to replace PMA or activated AC after stimulation with particle-bound anti-CD3. Purified CD4+ and CD8+ T cells behaved identically in all the experiments, indicating that the basic mechanisms for activation in the two T-cell subsets are identical.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957786     DOI: 10.1111/j.1365-3083.1987.tb02252.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Activation of human T lymphocytes: differential effects of CD3- and CD8-mediated signals.

Authors:  Y Samstag; F Emmrich; T Staehelin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.

Authors:  A Molloy; G Gaudernack; W R Levis; Z A Cohn; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Immunosuppression by breast cancer associated p43-effect of immunomodulators.

Authors:  H R Rosen; C Ausch; G Reiner; M Reinerova; J Svec; H Tüchler; R Schiessel; C Moroz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.

Authors:  J Verwilghen; M L Baroja; F Van Vaeck; J Van Damme; J L Ceuppens
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

5.  IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells.

Authors:  Shlomo Z Ben-Sasson; Alison Hogg; Jane Hu-Li; Paul Wingfield; Xi Chen; Michelle Crank; Stephane Caucheteux; Maya Ratner-Hurevich; Jay A Berzofsky; Ran Nir-Paz; William E Paul
Journal:  J Exp Med       Date:  2013-03-04       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.